Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel HDAC inhibitors in early development at Roche

Aug. 2, 2004

Antitumor colchicine derivatives prepared at Aventis

Aug. 2, 2004

Photodynamic therapy with Metvix shows efficacy in actinic cheilitis

July 30, 2004

Assessment of Bcl -2 family members as targets for antisense therapy in melanoma

July 30, 2004

Plantacor licenses preclinical cancer therapeutics from M. D. Anderson

July 30, 2004

Alimta receives positive endorsement from Advisory Committee for NSCLC

July 30, 2004

Novel VEGFR inhibitors prepared and tested by ImClone researchers

July 30, 2004

Novel antitumor and antifungal compounds developed at Gemin X

July 30, 2004

Agensys enters collaboration and license agreement with Genentech

July 29, 2004

Phase I trial of ON-01910Na commences enrollment

July 29, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...